The 2023 Clinical Pathways Congress is debuting a new partnership with the Cancer Care Business Exchange. Join us as we reimagine how the industry delivers and pays for cancer care.
This new collaboration expands the conversation to the stakeholders who have interest, influence, and impact on the evolving business models of cancer care and how innovation will continue to improve them.
Join us October 6–8 in Boston for business-changing insights, practical strategies, and key exchanges with innovators. Together we will devise practical strategies and actionable solutions to the business challenges facing today’s cancer care stakeholders.
Year after year, 97% of our attendees say the Congress increases their knowledge and meets their educational needs. Your registration includes access to insightful conversations with key opinion leaders, crucial education, meaningful networking, timely discussions with the industry’s top solution providers, and so much more.

Physician Emeritus, Finance & Quality Chair
Michiana Hematology-Oncology, PC
Mishawaka, Indiana

The Center for Cancer and Blood Disorders
Fort Worth, Texas

New Century Health
Brea, California

Carrum Health
Richmond, Virginia

National Cancer Treatment Alliance/Community Oncology Alliance
Washington, DC

Oncology Care Partners
La Grange, Tennessee

National Comprehensive Cancer Network
Ft. Washington, Pennsylvania

Cancer Center Business Development Group
Vero Beach, Florida

Patient Advocate Foundation &
National Patient Advocate Foundation
Hampton, Virginia

Spesana
Memphis, Tennessee

Foley & Lardner LLP
San Diego, California

Flatiron Health
Albuquerque, New Mexico

Buffalo, New York

Flatiron Health
Atlanta, Georgia

Valuate Health Consultancy
Overland Park, Kansas

Memorial Sloan Kettering
New York, New York

Tempus Labs
Chicago, Illinois
ADVI
Washington, DC

City of Hope
Duarte, California

New Mexico Oncology Hematology Consultants, Ltd
Albuquerque, New Mexico

Harvard Business School
Associate Faculty
Harvard School of Public Health and Brigham Health, Ariadne Labs
Boston, Massachusetts

ClinicalPath/Elsevier
Pittsburgh, Pennsylvania

Foley & Lardner LLP
Boston, Massachusetts
The Congress brings together the biggest names across the cancer care spectrum and provides a unique opportunity for meaningful engagement with payer- and provider-facing pathway architects. If you are interested in being a part of this year’s event, we encourage you to reach out to learn more about our partnership opportunities. Together we can unlock the potential of cancer care to deliver a brighter future for patients.
This program is designed for healthcare professionals interested in learning how to implement, maintain, and measure treatment pathways.